Back
Akero Therapeutics Stock Price Chart

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
50
AKRO
Akero Therapeutics
Last Price:
$54.14
Seasonality Move:
30.3%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.61 | Sell |
20-day SMA: | 51.97 | Buy |
50-day SMA: | 45.22 | Buy |
200-day SMA: | 37.36 | Buy |
8-day EMA: | 54.38 | Sell |
20-day EMA: | 51.87 | Buy |
50-day EMA: | 47.62 | Buy |
200-day EMA: | 39.21 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.93 | Buy |
Relative Strength Index (14 RSI): | 62.96 | Buy |
Chaikin Money Flow: | -901741 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.9 - 55.3) | Buy |
Bollinger Bands (100): | (39.56 - 52.16) | Buy |
Akero Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 54.20 while AKRO 8-day simple moving average is 54.61, which is a Sell signal.
-
The stock price of AKRO is 54.20 while Akero Therapeutics 20-day SMA is 51.97, which makes it a Buy.
-
Akero Therapeutics 50-day simple moving average is 45.22 while AKRO share price is 54.20, making it a Buy technically.
-
AKRO stock price is 54.20 and Akero Therapeutics 200-day simple moving average is 37.36, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a SellThe current Akero Therapeutics [AKRO] share price is $54.20. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Akero Therapeutics Stock Info
Market Cap:
4.3B
Price in USD:
54.20
Share Volume:
2M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
21.02
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 54.20 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 54.20 while AKRO 8-day exponential moving average is 54.38, which is a Sell signal.
-
The stock price of AKRO is 54.20 while Akero Therapeutics 20-day EMA is 51.87, which makes it a Buy.
-
Akero Therapeutics 50-day exponential moving average is 47.62 while AKRO share price is 54.20, making it a Buy technically.
-
AKRO stock price is 54.20 and Akero Therapeutics 200-day simple moving average is 39.21, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 2.93, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 62.96, which suggest Akero Therapeutics is overbought
-
The Bollinger Bands (25) for Akero Therapeutics is (44.9 - 55.3), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (39.56 - 52.16), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.